Oshima et al14 analyzed 11 years of data from the Japanese Adverse Drug Event Report database, finding that VEGF pathway inhibitors compared with non-VEGFR pathway inhibitors were associated with increased odds of aortic dissection (odds ratio, 22.3). This evidence concerns the gene VEGFA and Aortic dissection.